Skip to main content
Premium Trial:

Request an Annual Quote

Microarray Market Poised to Reach $3.6B by 2006, Report Says

NEW YORK, Nov. 13 - The DNA microarray market will grow to $3.6 billion over the next five years as academic institutions and pharmaceutical companies move to more aggressively adopt the instruments and prices start coming down, Front Line Strategic Consulting said in a report.

 

"Currently, costs are the largest barrier for widespread application of DNA microarray technology, however use should increase as prices decline over time," Front Line said in a statement announcing the anticipated release of its latest report, DNA Microarrays: A Strategic Market Analysis, on November 19.

 

"For example, growth in the integrated systems segment will occur at an average annual rate of 22 percent, driven by the price reduction of Affymetrix's GeneChip system, as well as by an increased use of pre-fabricated arrays in general as they become more affordable," Front Line said.

 

In a summary of the report, Front Line, of Foster City, Calif., said the scanner and arrayer markets would experience the greatest growth, with sales of these systems increasing at a compound annual growth rate of 44 percent, reaching $1.64 billion and $887 million, respectively, by 2006.

 

According to the report, Affymetrix, Apogent, and GeneMachines currently control 73 percent of the arrayer market. Affy is currently the leading company in that segment. 

 

The gradual use of microarrays as diagnostic tools will also help to spur growth in the sector, Front Line said.

The Scan

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.

Study Reviews Family, Provider Responses to Rapid Whole-Genome Sequencing Follow-up

Investigators identified in the European Journal of Human Genetics variable follow-up practices after rapid whole-genome sequencing.

BMI-Related Variants Show Age-Related Stability in UK Biobank Participants

Researchers followed body mass index variant stability with genomic structural equation modeling and genome-wide association studies of 40- to 72-year olds in PLOS Genetics.

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.